HeartWare Receives 54-Patient Allotment From FDA Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial

HeartWare Receives 54-Patient Allotment From FDA Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial

Submitted by moderatorj on March 16, 2012 - 11:17pm
Source: 
Yahoo/PRNewswire
News Tags: 
HeartWare
FDA
clinical trials
Headline: 
HeartWare Receives 54-Patient Allotment From FDA Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial

Do Not Allow Advertisers to Use My Personal information